Synthesis and biological evaluation of positron emission tomography radiotracers targeting serotonin 4 receptors in brain: [18F]MNI-698 and [18F]MNI-699
Graphical abstract
References and notes (29)
- et al.
Pharmacol. Rep.
(2009) - et al.
Neuropharmacology
(1994) - et al.
J. Neurol. Sci.
(2010) - et al.
Tetrahedron Lett.
(2003) - et al.
Mol. Imaging Biol.
(2003) - et al.
Synapse
(2000) - et al.
Br. J. Pharmacol.
(1993) - et al.
CNS Neurol. Disord.-Dr.
(2004) - et al.
Br. J. Pharmacol.
(1995) - et al.
Behav. Brain Res.
(1996)
Expert Opin. Invest. Drug
J. Neurosci.
J. Med. Chem.
Naunyn-Schmiedeberg’s Arch. Parmacol.
Cited by (21)
Kinetic isotope effects and synthetic strategies for deuterated carbon-11 and fluorine-18 labelled PET radiopharmaceuticals
2021, Nuclear Medicine and BiologyCitation Excerpt :Despite the relatively low affinity of [18F]129 for the 5-HT4 receptor compared to the suite of alternative ligands trialled, the deuterated tracer was further evaluated in a 2014 in vivo study [219]. From this translation, [18F]129 was found to exhibit high brain uptake with 50–60% of total radioligand binding being specific in the striatum, one of the most 5-HT4 receptor dense regions of the brain [220–222]. Furthermore, the distribution volume was found to be stable over 60 min scan durations, even in 5-HT4 receptor sparse regions such as the cerebellum [223], leading researchers to conclude that the deuterated radiotracer exhibited negligible formation of brain permeable radiometabolites [219].
Serotonergic imaging in Parkinson's disease
2021, Progress in Brain ResearchDistribution of 5-HT receptors in the central nervous system: an update
2020, Handbook of Behavioral NeuroscienceCitation Excerpt :Several compounds have been developed in recent years for the analysis of 5-HT4 receptors in the living brain by positron emission tomography. These include [11C]-SB207145 (Marner et al., 2009), [18F]-MNI-698 and [18F]-MNI-699 (Caille et al., 2013; Tavares et al., 2014a; 2014b), [11C]-RX-1 and [18F]-RX-2 (Lohith et al., 2014). One of them, [11C]-SB207145, has been used in human studies and helped determine that lower densities of 5-HT4 receptors in neocortex are associated with a particular polymorphism within the 5-HT transporter gene that results in its reduced transcriptional efficacy, which may contribute to increased serotonin levels (Fisher et al., 2012).
Serotonin receptor imaging by <sup>18</sup>F-PET
2018, Fluorine in Life Sciences: Pharmaceuticals, Medicinal Diagnostics, and Agrochemicals Progress in Fluorine Science Series